Clin2
NCT07605741Likely a fitNot yet recruiting

Fast Heart Bone Imaging for Suspected Heart Protein Disease

Cardiac Amyloidosis

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests a faster type of bone imaging scan to help diagnose a rare heart condition where an abnormal protein builds up in the heart muscle. Researchers want to see if this newer imaging method works better than standard scans for detecting this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 95 years
Study type
Observational

Who can take part

  • Your doctor referred you for a bone imaging scan because they suspect you may have transthyretin cardiac amyloidosis (a condition where an abnormal protein called transthyretin builds up in your heart)
  • You are willing to have your medical data used for research purposes
  • You were referred for this scan between April 2024 and April 2025

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06921408Not yet recruiting
Finding heart amyloidosis in bone scans

This study looks back at bone scans that were done for other reasons to see if they can spot a condition called cardiac amyloidosis, where abnormal protein builds up in the heart.

NCT04849754Recruiting
Monitoring heart amyloidosis with a special scan

This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.

Lille
NCT06427304Recruiting
Heart scan study for amyloid protein in older adults

This trial is testing older adults with heart failure to see if a heart condition called cardiac amyloidosis (a buildup of abnormal protein in the heart) is present. If you are 80 or older, have been in the hospital for heart failure in the past year, and have a thickened heart wall, you may be able to join.

Paris, IIe-de-France
NCT07538518Not yet recruiting
PET imaging to identify heart amyloidosis with new marker

This study uses a new imaging technique (PET scan with a tracer called evuzamitide) to detect a type of heart disease called cardiac amyloidosis in patients whose standard heart scans were unclear but who have elevated levels of a new blood marker (TAD1). The goal is to find a better way to diagnose this condition.

Boston, Massachusetts
NCT06790394Recruiting· Phase 1
Test-Retest PET Scan Study for Heart Amyloidosis

This study uses a special PET scan tracer to see how consistent the images are in people with heart amyloidosis (a buildup of abnormal protein in the heart) and in people without the condition. The goal is to improve diagnosis and monitoring.

London
NCT07560306Recruiting· Phase 3
New Heart Scan to Detect Blood Clots in Amyloid Heart Disease

This study tests a new type of imaging scan ([64Cu]FBP8 PET) to detect blood clots that may form in the heart's left atrial appendage (a small pouch in the heart) in patients with amyloid cardiomyopathy (a disease where abnormal protein builds up in heart muscle) who also have irregular heartbeat. The scan may help doctors catch clots earlier and prevent strokes.

Boston, Massachusetts

Hear when a new Cardiac Amyloidosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.